AllSight
Companies · IRTC · Surgical & Medical Instruments & Apparatus

iRhythm Holdings, Inc. (IRTC)

iRhythm Holdings, Inc. (IRTC) stock — the fundamentals (P/E, market cap, valuation) and every material event, decoded in plain English.

iRhythm Holdings, Inc. (IRTC) stock — financials & valuation

Key numbers for iRhythm Holdings, Inc. (IRTC): P/E ratio, market cap, profit margins, returns, and whether the stock looks cheap or expensive versus its own 5-year range.

AllSight quality score: 36/100 — a percentile rank of iRhythm Holdings, Inc.’s fundamentals against Manufacturing peers, weakest on valuation. A quality ranking, not a price prediction.

Market cap$3.7B
P / S4.4×
EV / EBITDA303.6×
Gross margin71.5%
Operating margin-3.0%
Net margin-1.7%
Return on equity-7.5%
ROIC-4.5%
Revenue growth25.6%
Debt / equity3.5×
Dividend yield0.0%

Is iRhythm Holdings, Inc. overvalued? P/S looks undervalued vs its 5-year range; P/B looks fair vs its 5-year range.

Independent of the events above — derived from iRhythm Holdings, Inc.’s own financial statements and shown as context, never as advice.

Sep 22, 2026VitalConnect acquisition
iRhythm reaffirms VitalConnect acquisition, but adds no new terms
Aug 13, 2026Audit chair transition
Audit chair quits—but the internal handoff keeps the disruption contained
Aug 6, 2026
VitalConnect deal broadens reach, but near-term economics remain unproven
Aug 6, 2026
VitalConnect broadens the platform, but deal economics remain unproven
Related companies in Surgical & Medical Instruments & Apparatus
Open live on AllSight — the whole market, decoded →

About AllSight · Editorial standards & method · Contact